Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34170745

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Oct 1
First author
Moskowitz AJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    3097
    note
    Source null
    related pmid
    Source null
    relationship
    Comment in
    url
    Source null

Authors and identifiers

  1. name
    Moskowitz AJ
    type
    Author
  2. name
    Shah G
    type
    Author
  3. name
    Schöder H
    type
    Author
  4. name
    Ganesan N
    type
    Author
  5. name
    Drill E
    type
    Author
  6. name
    Hancock H
    type
    Author
  7. name
    Davey T
    type
    Author
  8. name
    Perez L
    type
    Author
  9. name
    Ryu S
    type
    Author
  10. name
    Sohail S
    type
    Author
  11. name
    Santarosa A
    type
    Author
  12. name
    Galasso N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Moskowitz AJ
    type
    Author
  2. name
    Shah G
    type
    Author
  3. name
    Schöder H
    type
    Author
  4. name
    Ganesan N
    type
    Author
  5. name
    Drill E
    type
    Author
  6. name
    Hancock H
    type
    Author
  7. name
    Davey T
    type
    Author
  8. name
    Perez L
    type
    Author
  9. name
    Ryu S
    type
    Author
  10. name
    Sohail S
    type
    Author
  11. name
    Santarosa A
    type
    Author
  12. name
    Galasso N
    type
    Author
bibliography ids
  1. nci-bib-75bdeea529b1cbcb75a4a787
book metadata
content sha256
fdf334c412f418af0d18d93785b38e6aa708432cc6e1617835af1399cd2994c5
document type
citation
dois
  1. 10.1200/JCO.21.01056
electronic publication date
display
2021 Jun 25
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34170745
immutable id
pubmed:34170745@fdf334c412f418af0d18d93785b38e6aa708432cc6e1617835af1399cd2994c5
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
28
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3109-3117
volume
39
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    3097
    note
    Source null
    related pmid
    Source null
    relationship
    Comment in
    url
    Source null
outcomes validated
false
pmid
34170745
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
3fdb2b38fa566bf2ecaaac1bcb3cbc1e25fa04d4109b1ae96303bc9648521a9e
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Oct 1
precision
day
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34170745/
title
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.

Preserved source evidence · Not medical advice